TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6356005

Group type: EXPERIMENTAL
Intervention: Ribavirin aerosol (10 mg/kg body weight, daily 12-hour treatments over 5 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline aerosol (control)
Number of subjects: 26
Study: 31119456

Group type: EXPERIMENTAL
Intervention: Pre‐meal rapid‐acting insulin
Number of subjects: 71

Group type: COMPARATOR
Intervention: No insulin (control)
Number of subjects: 71
Study: 29378662

Group type: EXPERIMENTAL
Intervention: ART refills supplied 3-monthly within CARGs
Number of subjects: 5760

Group type: EXPERIMENTAL
Intervention: ART refills supplied 6-monthly within CARGs
Number of subjects: 5760

Group type: COMPARATOR
Intervention: ART refills supplied 3-monthly from the health facility (control arm)
Number of subjects: 5760
Study: 27460321

Group type: EXPERIMENTAL
Intervention: Lava COS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: iTero
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cerec Bluecam
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional impression
Number of subjects: 10
Study: 24784879

Group type: EXPERIMENTAL
Intervention: Helmet therapy (n=42)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Natural course (n=42)
Number of subjects: 84
Study: 21739259

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 20950883

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing based counselling training for nurses
Number of subjects: 584

Group type: COMPARATOR
Intervention: Control group (nurses trained after the study)
Number of subjects: 584
Study: 17659159

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/day added to ongoing statin therapy
Number of subjects: 5039

Group type: COMPARATOR
Intervention: Placebo added to ongoing statin therapy
Number of subjects: 5039
Study: 16338558

Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis (LASIK)
Number of subjects: 18
Study: 12522743

Group type: EXPERIMENTAL
Intervention: Exercise intervention program based on the transtheoretical model, including written materials and teaching activities for different stages of exercise.
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 193
Study: 9789893

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide 1.2 to 2.0 mg/day for 6 to 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7706098

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 30

Group type: COMPARATOR
Intervention: 45-degree upright position
Number of subjects: 30
Study: 2705633

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no gemfibrozil)
Number of subjects: 44
Study: 701664

Group type: EXPERIMENTAL
Intervention: Polymerized ragweed
Number of subjects: 19

Group type: COMPARATOR
Intervention: Monomeric ragweed
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 30361759

Group type: EXPERIMENTAL
Intervention: ETT cuff pressure adjusted to 20 mmHg after retractor placement
Number of subjects: 162

Group type: COMPARATOR
Intervention: No adjustment of ETT cuff pressure
Number of subjects: 162
Study: 27671007

Group type: EXPERIMENTAL
Intervention: Postnatal additional high-dose oral vitamin A supplementation for 28 days (exact dosage not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basic vitamin A (1000 IU/kg/day)
Number of subjects: 0
Study: 26046790

Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI) cystoscopy
Number of subjects: 384

Group type: COMPARATOR
Intervention: White-light imaging (WLI) cystoscopy
Number of subjects: 384
Study: 23022464

Group type: EXPERIMENTAL
Intervention: 6 μg HA with 300 μg aluminum phosphate (AlPO4)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 6 μg HA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3 μg HA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 60
Study: 21807321

Group type: EXPERIMENTAL
Intervention: BNP-guided therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Clinical assessment alone (Control)
Number of subjects: 130
Study: 19929037

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillators (ICDs)
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: ICDs
Number of subjects: 983
Study: 16616620

Group type: EXPERIMENTAL
Intervention: Prone positioning for 20 hours each day during the acute phase for a maximum of 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 0
Study: 12745612

Group type: COMPARATOR
Intervention: Natural history phase
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo phase
Number of subjects: 138
Study: 11081892

Group type: EXPERIMENTAL
Intervention: ANP treatment (0.05 microg x kg(‐1) x min(‐1) for 6 hours)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No ANP treatment (control group)
Number of subjects: 18
Study: 8931065

Group type: EXPERIMENTAL
Intervention: Non-pharmacological intervention (weekly sessions with a nurse over 3-6 weeks using counselling, breathing re‐training, relaxation, and teaching coping strategies)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Non-pharmacological intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 1406008

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Placebo cream
Number of subjects: 73

Group type: COMPARATOR
Intervention: No cream (control)
Number of subjects: 73
Study: 3159163

Group type: EXPERIMENTAL
Intervention: muzolimine (20 mg once daily for three weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: nitrendipine (10 mg twice daily for four weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: captopril (25 mg twice daily for four weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: muzolimine plus nitrendipine plus captopril (same dosages for four weeks)
Number of subjects: 30
Study: 30082139

Group type: EXPERIMENTAL
Intervention: Closed-suction drain
Number of subjects: 223

Group type: COMPARATOR
Intervention: Passive gravity drain
Number of subjects: 223
Study: 27106949

Group type: EXPERIMENTAL
Intervention: Self-efficacy-based breast feeding educational programme (SEBEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 0
Study: 24787561

Group type: EXPERIMENTAL
Intervention: Instantaneous audiovisual feedback training
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (previous year's participants)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Feedback group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 200
Study: 22396514

Group type: EXPERIMENTAL
Intervention: Standardized anteromesial temporal resection (AMTR) plus AED treatment (n = 15)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Continued AED treatment (n = 23)
Number of subjects: 38
Study: 20498393

Group type: EXPERIMENTAL
Intervention: FU-based therapy (either FU + levamisole or FU + leucovorin)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: FU (in patients with dMMR tumors)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Surgery alone (control group for dMMR patients)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: FU-based therapy (in pooled data set)
Number of subjects: 457
Study: 18356346

Group type: EXPERIMENTAL
Intervention: Routine blood pressure measurement and written information about hypertension with advice to see a general practitioner if indicated
Number of subjects: 400

Group type: COMPARATOR
Intervention: No measurement or advice (Control)
Number of subjects: 400
Study: 15318470

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 90
Study: 11228380

Group type: EXPERIMENTAL
Intervention: QS‐21 (50 and 100 microg)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: rsgp120 formulated with QS‐21
Number of subjects: 3

Group type: COMPARATOR
Intervention: rsgp120 formulated with alum alone
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: QS‐21 formulations
Number of subjects: 3
Study: 9052304

Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5% (10 mL)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Saline (10 mL)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control sham (0.5 mL saline)
Number of subjects: 8
Study: 8300895

Group type: EXPERIMENTAL
Intervention: Sublingual estradiol hydroxypropyl‐beta‐cyclodextrin (estradiol‐HP beta CD) 0.675 mg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Oral micronized estradiol 1 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sublingual estradiol hydroxypropyl‐beta‐cyclodextrin (estradiol‐HP beta CD)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Oral estradiol hydroxypropyl‐beta‐cyclodextrin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Oral micronized estradiol
Number of subjects: 5

Group type: COMPARATOR
Intervention: Both oral doses (estradiol-HP beta CD and micronized estradiol)
Number of subjects: 5
Study: 3079477

Group type: EXPERIMENTAL
Intervention: 5-FU plus leucovorin (CF)
Number of subjects: 0
Study: 31595772

Group type: EXPERIMENTAL
Intervention: Current use of benzodiazepines
Number of subjects: 10263

Group type: COMPARATOR
Intervention: Nonusers of benzodiazepines
Number of subjects: 10263
Study: 30441880

Group type: EXPERIMENTAL
Intervention: Low Antioxidant Diet (LAD), with less than two servings of fruit and vegetables per day, avoiding cocoa products, coffee, and tea.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual Diet (UD), consuming healthy food rich in polyphenols.
Number of subjects: 22
Study: 27558901

Group type: EXPERIMENTAL
Intervention: Controlled release oxycodone plus naloxone up to 20 mg per day
Number of subjects: 346

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study: 24025063

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 22854394

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.5% plus 150 μg clonidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Levobupivacaine 0.5%
Number of subjects: 60
Study: 20001576

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed 100 whey formula (pHF)
Number of subjects: 15
Study: 18588370

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus intravenous infusions of cyclophosphamide 15 mg/kg daily for two days, methylprednisolone one gram daily for three days, and mesna 15 mg/kg for four days.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional treatment.
Number of subjects: 45
Study: 16808365

Group type: EXPERIMENTAL
Intervention: Single dose of prophylactic antibiotics
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1040
Study: 12900339

Group type: COMPARATOR
Intervention: TAXUS-SR
Number of subjects: 536

Group type: COMPARATOR
Intervention: TAXUS-MR
Number of subjects: 536
Study: 10634839

Group type: EXPERIMENTAL
Intervention: Thiopental 6 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 30
Study: 8857657

Group type: EXPERIMENTAL
Intervention: 4 mg/kg ketamine + 0.1 mg/kg diazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 8 mg/kg ketamine + 0.1 mg/kg diazepam
Number of subjects: 0
Study: 1349217

Group type: EXPERIMENTAL
Intervention: Activated charcoal (25 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chloroquine (500 mg)
Number of subjects: 12
Study: 6381344

Group type: EXPERIMENTAL
Intervention: Chronic oral amrinone therapy (100 mg orally every 8 hours for 4 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31917595

Group type: EXPERIMENTAL
Intervention: Environmental factors (presence of stagnant wastewater, flies, solid waste, water-filled containers near households, distance from the river)
Number of subjects: 205
Study: 30481374

Group type: EXPERIMENTAL
Intervention: 3.75 mg/mL ropivacaine infiltration followed by 2 mg/mL ropivacaine continuous wound infiltration (CWI) for 96 hours
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (P) for 96 hours
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 3.75 mg/mL ropivacaine infiltration followed by 2 mg/mL ropivacaine CWI
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 85
Study: 30208394

Group type: EXPERIMENTAL
Intervention: Low-efficiency (LE) high-efficiency particulate arrestance (HEPA)-type filtered air
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-efficiency (HE) true-HEPA filtered air
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham filtration (unfiltered air)
Number of subjects: 40
Study: 29771066

Group type: EXPERIMENTAL
Intervention: Intratympanic budesonide injection
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dexamethasone (control group-1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group-2 (systemic therapy without intratympanic steroid injection)
Number of subjects: 90
Study: 24889399

Group type: EXPERIMENTAL
Intervention: DLBP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LDH
Number of subjects: 60

Group type: COMPARATOR
Intervention: CLBP
Number of subjects: 60

Group type: COMPARATOR
Intervention: N
Number of subjects: 60
Study: 21848574

Group type: EXPERIMENTAL
Intervention: prucalopride 2 mg once daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: prucalopride 10 mg once daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo with 400 mg moxifloxacin on day 1
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo with moxifloxacin on day 15
Number of subjects: 120
Study: 19472537

Group type: EXPERIMENTAL
Intervention: Deep MMC (D‐MMC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Superficial MMC (S‐MMC)
Number of subjects: 25
Study: 17574858

Group type: EXPERIMENTAL
Intervention: Desflurane preconditioning (2.5 minimum alveolar concentration for 5 minutes)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (desflurane-free bypass for 15 minutes)
Number of subjects: 28
Study: 15238031

Group type: EXPERIMENTAL
Intervention: Sentence stems presented in the study phase
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sentence stems presented in the test phase
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sentence stems presented in both study and test phases
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Highly constrained terminal words
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Merely consistent terminal words
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Incongruous terminal words
Number of subjects: 5
Study: 11903856

Group type: EXPERIMENTAL
Intervention: Slow-release caffeine (SRC) 300 mg given twice daily (21:00 and 9:00 h) during SD
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 16
Study: 9477010

Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 8201484

Group type: EXPERIMENTAL
Intervention: Office-based educational intervention (physician advice and written material on cloth and disposable diapers)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Hospital practices (exclusive use of cloth diapers)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 193
Study: 3427561

Group type: EXPERIMENTAL
Intervention: Progabide (PGB)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 29545635

Group type: EXPERIMENTAL
Intervention: Plecanatide 3 mg
Number of subjects: 2189

Group type: EXPERIMENTAL
Intervention: Plecanatide 6 mg
Number of subjects: 2189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2189

Group type: EXPERIMENTAL
Intervention: Plecanatide 3 mg and 6 mg
Number of subjects: 2189
Study: 27625066

Group type: EXPERIMENTAL
Intervention: Exception to consent process in a paediatric resuscitation trial (SQUEEZE)
Number of subjects: 25
Study: 24090176

Group type: EXPERIMENTAL
Intervention: Personalized feedback (PF) provided in the context of modified behavioral self‐control therapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Personalized feedback (PF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Severity of personalized feedback (PF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Other drug risk, family risk, and having an abnormal liver enzyme test result
Number of subjects: 90
Study: 22623080

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketofol
Number of subjects: 90
Study: 19945857

Group type: EXPERIMENTAL
Intervention: PTK787/ZK222584 (PTK/ZK) at a dose of 1000 mg once daily in combination with radiotherapy and temozolomide (TMZ)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PTK787/ZK222584 (PTK/ZK) at a dose of 1250 mg once daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard adjuvant dose of temozolomide (TMZ)
Number of subjects: 20
Study: 19094430

Group type: EXPERIMENTAL
Intervention: Thiamine pyrophosphate (TPP) 1 mg/kg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 27
Study: 15917023

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including opinion leaders, consensus processes, computer-delivered cessation care, computer-generated prompts, staff training, and performance feedback.
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual cessation care
Number of subjects: 210
Study: 12545147

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 microg subcutaneously)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 14626338

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol combination (FSC) 100/50 or 250/50 microg twice daily
Number of subjects: 686

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP)
Number of subjects: 686

Group type: COMPARATOR
Intervention: Salmeterol (SAL)
Number of subjects: 686
Study: 10535881

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 85
Study: 7850943

Group type: EXPERIMENTAL
Intervention: Electrophysiological testing (EPS)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Holter monitoring (HM)
Number of subjects: 286
Study: 2083526

Group type: EXPERIMENTAL
Intervention: Toothbrush
Number of subjects: 19

Group type: COMPARATOR
Intervention: Chewing stick
Number of subjects: 19
Study: 291122

Group type: EXPERIMENTAL
Intervention: RAP + T (daunorubicine, cytarabine, prednisone + thioguanine)
Number of subjects: 194

Group type: COMPARATOR
Intervention: RAP (daunorubicine, cytarabine, prednisone)
Number of subjects: 194

Group type: COMPARATOR
Intervention: RAP
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: RAP + T
Number of subjects: 194
Study: 28418966

Group type: EXPERIMENTAL
Intervention: Methadone 0.2 mg/kg at the start of surgery
Number of subjects: 120
Study: 26018333

Group type: EXPERIMENTAL
Intervention: Estradiol (100 µg/d)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no history of depression)
Number of subjects: 56
Study: 22882966

Group type: EXPERIMENTAL
Intervention: Decision aid group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 240
Study: 22059222

Group type: EXPERIMENTAL
Intervention: Group lifestyle support program
Number of subjects: 20
Study: 19419306

Group type: EXPERIMENTAL
Intervention: teriparatide treatment (20 microg/d)
Number of subjects: 44
Study: 17304653

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab (no preexisting protective antibody titers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (no preexisting protective antibody titers)
Number of subjects: 0
Study: 15549548

Group type: EXPERIMENTAL
Intervention: Topiramate (100 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11405325

Group type: EXPERIMENTAL
Intervention: Previous hematopoietic malignancy
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: History of hives
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Benzene exposure > 810 days
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Daily welding
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Activity of radio operator
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Agricultural professional
Number of subjects: 1025
Study: 9146256

Group type: EXPERIMENTAL
Intervention: Baseline multidisciplinary cultural assessment survey
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 7974899

Group type: EXPERIMENTAL
Intervention: Early endocrine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endocrine therapy plus radical prostatectomy
Number of subjects: 0
Study: 2884797

Group type: EXPERIMENTAL
Intervention: Vecuronium (20 micrograms/kg priming dose, 60 micrograms/kg intubating dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Atracurium (100 micrograms/kg priming dose, 300 micrograms/kg intubating dose)
Number of subjects: 20
Study: 30594763

Group type: EXPERIMENTAL
Intervention: Passive coping styles
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Negative life events
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Subjective Well-being under Neuroleptics-20 (SWN-20) scale
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Utrechtse Coping Lijst (UCL)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Interview of the Recent Life Event Scale (IRLES)
Number of subjects: 568